This Week at FDA: Updated guidance on denying inspections and biosimilar interchangeability

This Week at FDA

This Week at FDAFerdous Al-Faruque • Michael Mezher

GenericsGovernment/legislationGuidanceMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)